WeVote

Bill

Bill

HB 3367

Compound prescriptions; electronic prescriptions; effective date.

2026 Regular Session Introduced by Danny Williams

HB 3367 establishes Oklahoma pharmacy regulations for compounded prescriptions and electronic prescription systems to improve medication safety and modernize prescription management practices.

Referred to Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 3367

Legislative bill overview

HB 3367 addresses the regulation of compound prescriptions and electronic prescription processes in Oklahoma. The bill establishes procedures and requirements for how pharmacies handle compounded medications and manage e-prescription systems, with a specified effective date for implementation.

Why is this important

Compounded prescriptions (custom-mixed medications) and electronic prescription systems are critical to pharmacy operations and patient medication access. Clear regulatory frameworks ensure patient safety, prevent medication errors, and modernize healthcare delivery while maintaining quality standards across the state's pharmacy network.

Potential points of contention

  • Pharmacy burden vs. patient safety: Requirements for compounding oversight may increase operational costs for smaller pharmacies while proponents argue safety protections justify the expense
  • E-prescription standardization: Mandating electronic systems could create compatibility issues with existing pharmacy software and healthcare provider systems during transition periods
  • Scope of practice definitions: Unclear how compounding authority is divided between pharmacists, technicians, and outsourced facilities may create jurisdictional disputes or competitive concerns

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.